1)Tansarli GS, Mylonakis E:Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults. Antimicrob Agents Chemother 62:e00635-18, 2018
2)Dimopoulos G, et al:Short- versus long-course antibacterial therapy for community-acquired pneumonia;A meta-analysis. Drugs 68:1841-1854, 2008
3)Metlay JP, et al:Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200:e45-e67, 2019
4)Gilbert DN, et al(ed):The Sanford Guide to Antimicrobial Therapy 2020. Antimicrobial Therapy, Sperryville, 2020
5)Woodhead M, et al:Guidelines for the management of adult lower respiratory tract infections;Full version. Clin Microbiol Infect 17(Suppl 6):E1-59, 2011
6)Lim WS, et al:BTS guidelines for the management of community acquired pneumonia in adults;Update. Thorax 64(Suppl 3):iii1-iii55, 2009
7)Moussaoui R el, et al:Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia;Randomised, double blind study. BMJ 332:1355, 2006
8)Talan DA, et al:Comparison of ciprofloxacin(7 days)and trimethoprim-sulfamethoxazole(14 days)for acute uncomplicated pyelonephritis pyelonephritis in women;A randomized trial. JAMA 283:1583-1590, 2000
9)Peterson J, et al:A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology 71:17-22, 2008
10)Sandberg T, et al:Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis;A randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet 380:484-490, 2012
11)van Nieuwkoop C, et al:Treatment duration of febrile urinary tract infection;A pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women. BMC Med 15:70, 2017
12)Yahav D, et al:Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia;A noninferiority randomized controlled trial. Clin Infect Dis 69:1091-1098, 2019
13)Lipsky BA, et al:Treatment of bacterial prostatitis. Clin Infect Dis 50:1641-1652, 2010
14)V J Sharp, et al:Prostatitis;Diagnosis and treatment. Am Fam Physician. 82:397-406, 2010
15)Lipsky BA:Prostatitis and urinary tract infection in men;What's new, what's true? Am J Med 106:327-334, 1999
16)Ulleryd P, et al:Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men;A randomized trial with a 1 year follow-up. Scand J Infect Dis 35:34-39, 2003